Latest News Releases From The Newsroom
Fluor, LyondellBasell, and DT Midstream: Bullish Views
October 04th, 2023
UBS upgraded Fluor Corporation (NYSE: FLR), a leading engineering and construction company, from Neutral to Buy and raised the price target from $35 to $47 With $FLR closing at $34.62 on Tuesday, the new price target implies a potential upside of . Read more
Brooge Energy Becomes Takeover Target; A10 Networks Sees Below-Consensus Revenue
October 03rd, 2023
Shares of Brooge Energy Ltd. (Nasdaq: BROG) surged by more than 20% in after-hours trading as Gulf Navigation Holdings PJSC (GULFNAV), a Dubai-based maritime and shipping company, submitted a formal proposal to fully acquire all of Brooge Energy Limi. Read more
ALX Oncology's Evorpacept Data Sparks Momentum; McCormick Q3 Sales Miss
October 03rd, 2023
Shares of ALX Oncology Holdings Inc. (Nasdaq: ALXO) surged by more than 100% in pre-market trading after the company unveiled positive interim Phase 2 data from the ASPEN-06 clinical trial evaluating its CD47 blocking therapeutic evorpacept in combin. Read more
Momentum Builds for ALX Oncology and Delta Apparel
October 03rd, 2023
Shares of ALX Oncology Holdings Inc. (Nasdaq: ALXO) surged by more than 20% in after-hours trading following the announcement that it will unveil interim Phase 2 ASPEN-06 clinical trial results of evorpacept, aimed at treating advanced HER2-positive . Read more
Lockheed Martin, Boeing, and Northrop Grumman: Defense Contracts Wins
October 02nd, 2023
Lockheed Martin Rotary and Mission Systems, a business segment of Lockheed Martin Corporation (NYSE: LMT), has been granted a $10,854,384 cost-plus-fixed-fee modification to a previously awarded contract for Extra Large Unmanned Undersea Vehicle engi. Read more
Market Buzz: CDI Trial Outcome Fuels Acurx Pharmaceuticals
October 02nd, 2023
Shares of Acurx Pharmaceuticals, Inc. (Nasdaq: ACXP) surged by more than 20% in pre-market trading following the company's decision to discontinue its Phase 2b clinical trial of ibezapolstat, its lead antibiotic candidate, designed for the treatment . Read more
Bullish Views for Nextracker and Sunnova Energy
October 02nd, 2023
UBS has initiated coverage on Nextracker Inc. (Nasdaq: NXT), a notable player in the energy technology sector, with a Buy rating and a price target of $50. Closing at $40.16 on Friday, this price target suggests a substantial potential upside of $. Read more
Earnings Countdown: Lamb Weston, Conagra Brands, and Levi Strauss in Focus
October 01st, 2023
Some companies scheduled to disclose their financial results on Thursday, October 5, are: Lamb Weston Holdings, Inc. (NYSE: LW), a key player in the food industry, will release its fiscal first-quarter 2024 financial results before the market open. Read more
September Vehicle Delivery: Li Auto, XPeng, and NIO By The Numbers
October 01st, 2023
Li Auto Inc. (Nasdaq: LI) achieved a significant milestone with 36,060 vehicle deliveries in September 2023, marking a 212.7% year-over-year increase. The company's Q3 deliveries totaled 105,108, up by 296.3% compared to the previous year. In 2023, L. Read more
President Joe Biden's Relief: Government Averts Shutdown, Ukraine Support Remains a Concern
October 01st, 2023
President Joe Biden expressed relief as bipartisan majorities in the House and Senate successfully voted to avert a government shutdown, sparing millions of Americans from unnecessary hardship. This legislation guarantees the continued payment of act. Read more
Want To Find Some News?
News By Industries
Recent Posts
-
Key Earnings Ahead for Netflix, Fastenal, and U.S. Bancorp
January 18th, 2026Louisville Thunder Appoints Veteran Coach Mike Reed to Lead Program
January 15th, 2026FDA Approves First Treatment for Children With Menkes Disease
January 13th, 2026January 13th, 2026Wall Street Eyes Bank of America, Wells Fargo, Citi Ahead of Earnings
January 11th, 2026
Member Login